top of page
Coming Up Next
BCG Vesiculture shortage.
Areva has been working to mitigate the nationwide shortage of BCG, a bladder cancer treatment.
​​
​
The Food and Drug Administration’s top scientist Namandjé Bumpus will assume the role of principal deputy commissioner when longtime agency leader Janet Woodcock retires from that role in early 2024,...
FDA investigating cancer risk linked to CAR-T cell therapy
The agency is weighing the “need for regulatory action,” but said the benefit of approved treatments still outweighs any such risk..
The Food and Drug Adminsitration is investigating whether CAR-T cell therapies like Novartis’ Kymriah or Gilead’s Yescarta are linked to the risk of new blood cancers after receiving reports.
bottom of page